Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases
ACS Infectious Diseases · 2026
DOI: 10.1021/acsinfecdis.5c00860 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2026. Verfasst von Chelsea A Mann und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States. Hauptthemen laut MEDLINE: Bacillus anthracis, Anti-Bacterial Agents, Topoisomerase II Inhibitors, DNA Topoisomerases, Type II. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, Division of Microbiology and Infectious Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
- Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Fort Detrick, Maryland 21702, United States.
- Division of Medicinal Chemistry and Pharmacognosy, The Ohio State University College of Pharmacy, Columbus, Ohio 43210, United States.
- Departments of Biochemistry and Medicine (Hematology/Oncology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
ORCID-Profile: Chelsea A Mann, Mark J Mitton-Fry, J Matthew Meinig, Neil Osheroff
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- Division of Microbiology and Infectious Diseases
- Defense Threat Reduction Agency
- National Institute of General Medical Sciences
- JobsOhio Early-Stage Technology Fund
Zitieren
APA
Mann, C. A., Halasohoris, S. A., Gray, A. M., Chua, J., Spencer, J. L., Curry, B. J., Babyak, A. L., Klimko, C. P., Cote, C. K., West, J. S., Mitton-Fry, M. J., Meinig, J. M., & Osheroff, N. (2026). Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00860
Vancouver
Mann CA, Halasohoris SA, Gray AM, Chua J, Spencer JL, Curry BJ, et al. Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases. ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.5c00860
BibTeX
@article{Mann2026,
author = {Mann, Chelsea A and Halasohoris, Stephanie A and Gray, Annette M and Chua, Jennifer and Spencer, Jade L and Curry, Bobby J and Babyak, Ashley L and Klimko, Christopher P and Cote, Christopher K and West, Jason S and Mitton-Fry, Mark J and Meinig, J Matthew and Osheroff, Neil},
title = {Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases},
journal = {ACS Infectious Diseases},
year = {2026},
doi = {10.1021/acsinfecdis.5c00860}
}
EUVIMED